·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ÀǺ¸°ø´Ü, ÀǷẸÇè ÅëÇÕ È¨ÆäÀÌÁö ±¸Ãà ±â»çÀÔ·Â : 00.06.18 20:38:00 0 °¡ ÇÃÄ£Ãß°¡ ÅëÇÕÀǷẸÇè¾È³»¡¤ÅëÇÕ ´çÀ§¼º¡¤Àǰ߶õ ¸¶·Ã ÀǷẸÇè°ü¸®°ø´ÜÀº ÃÖ±Ù ÀǷẸÇè ÅëÇÕ¿¡ °üÇÑ È¨ÆäÀÌÁö(www.nhic.or.kr/tonghap)¸¦ ±¸ÃàÇß´Ù. ÀǺ¸ÅëÇÕ È¨ÆäÀÌÁö´Â 7¿ù 1ÀϺÎÅÍ Ãâ¹üÇÏ´Â ±¹¹Î°Ç° º¸Çè°ø´ÜÀÇ ÃëÁö¸¦ ¾Ë¸®±â À§ÇØ ±¸Ãà, ¿î¿µÁß¿¡ ÀÖ´Ù. ȨÆäÀÌÁö´Â ±¹¹ÎÀǷẸÇè °ü¸®°ø´ÜÀÇ È¨ÆäÀÌÁö¿Í º°µµ·Î ±¸ºÐµÅ ¿î¿µµÇ°í ÀÖ´Â °¡¿îµ¥ ÀǷẸÇè ÅëÇÕÀÇ ¹è°æ°ú Çʿ伺°ú ÅëÇÕÀÇ ´çÀ§¼º¿¡ ´ëÇÑ ÀÔÀåÀ» ¼Ò°³Çϰí ÀÖ´Ù. ¶Ç ÅëÇÕÀǷẸÇè¾È³», ÅëÇÕÀÇ ´çÀ§¼º, ÅëÇÕ ¹Ý´ëÀǰ߿¡ ´ëÇÑ ´äº¯, ÀǺ¸ÅëÇÕ¿¡ ´ëÇÑ ÀÔÀå, ½É»çÆò°¡¿øµîÀÇ ÄÁÅÙÃ÷·Î ±¸¼ºµÅÀÖ´Ù. X AD ½ÉÆ÷Áö¾ö ´Ù½Ãº¸±â À̺¥Æ®Âü¿© ¡æ ¾È»ó¼ø ±âÀÚ(s2a@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀǺ¸°ø´Ü, ÀǷẸÇè ÅëÇÕ È¨ÆäÀÌÁö ±¸Ãà URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÀǺ¸°ø´Ü, ÀǷẸÇè ÅëÇÕ È¨ÆäÀÌÁö ±¸Ãà ±â»çÀÔ·Â : 00.06.18 20:38:00 0 °¡ ÇÃÄ£Ãß°¡ ÅëÇÕÀǷẸÇè¾È³»¡¤ÅëÇÕ ´çÀ§¼º¡¤Àǰ߶õ ¸¶·Ã ÀǷẸÇè°ü¸®°ø´ÜÀº ÃÖ±Ù ÀǷẸÇè ÅëÇÕ¿¡ °üÇÑ È¨ÆäÀÌÁö(www.nhic.or.kr/tonghap)¸¦ ±¸ÃàÇß´Ù. ÀǺ¸ÅëÇÕ È¨ÆäÀÌÁö´Â 7¿ù 1ÀϺÎÅÍ Ãâ¹üÇÏ´Â ±¹¹Î°Ç° º¸Çè°ø´ÜÀÇ ÃëÁö¸¦ ¾Ë¸®±â À§ÇØ ±¸Ãà, ¿î¿µÁß¿¡ ÀÖ´Ù. ȨÆäÀÌÁö´Â ±¹¹ÎÀǷẸÇè °ü¸®°ø´ÜÀÇ È¨ÆäÀÌÁö¿Í º°µµ·Î ±¸ºÐµÅ ¿î¿µµÇ°í ÀÖ´Â °¡¿îµ¥ ÀǷẸÇè ÅëÇÕÀÇ ¹è°æ°ú Çʿ伺°ú ÅëÇÕÀÇ ´çÀ§¼º¿¡ ´ëÇÑ ÀÔÀåÀ» ¼Ò°³Çϰí ÀÖ´Ù. ¶Ç ÅëÇÕÀǷẸÇè¾È³», ÅëÇÕÀÇ ´çÀ§¼º, ÅëÇÕ ¹Ý´ëÀǰ߿¡ ´ëÇÑ ´äº¯, ÀǺ¸ÅëÇÕ¿¡ ´ëÇÑ ÀÔÀå, ½É»çÆò°¡¿øµîÀÇ ÄÁÅÙÃ÷·Î ±¸¼ºµÅÀÖ´Ù. X AD ½ÉÆ÷Áö¾ö ´Ù½Ãº¸±â À̺¥Æ®Âü¿© ¡æ ¾È»ó¼ø ±âÀÚ(s2a@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀǺ¸°ø´Ü, ÀǷẸÇè ÅëÇÕ È¨ÆäÀÌÁö ±¸Ãà URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÀǺ¸°ø´Ü, ÀǷẸÇè ÅëÇÕ È¨ÆäÀÌÁö ±¸Ãà ±â»çÀÔ·Â : 00.06.18 20:38:00 0 °¡ ÇÃÄ£Ãß°¡ ÅëÇÕÀǷẸÇè¾È³»¡¤ÅëÇÕ ´çÀ§¼º¡¤Àǰ߶õ ¸¶·Ã ÀǷẸÇè°ü¸®°ø´ÜÀº ÃÖ±Ù ÀǷẸÇè ÅëÇÕ¿¡ °üÇÑ È¨ÆäÀÌÁö(www.nhic.or.kr/tonghap)¸¦ ±¸ÃàÇß´Ù. ÀǺ¸ÅëÇÕ È¨ÆäÀÌÁö´Â 7¿ù 1ÀϺÎÅÍ Ãâ¹üÇÏ´Â ±¹¹Î°Ç° º¸Çè°ø´ÜÀÇ ÃëÁö¸¦ ¾Ë¸®±â À§ÇØ ±¸Ãà, ¿î¿µÁß¿¡ ÀÖ´Ù. ȨÆäÀÌÁö´Â ±¹¹ÎÀǷẸÇè °ü¸®°ø´ÜÀÇ È¨ÆäÀÌÁö¿Í º°µµ·Î ±¸ºÐµÅ ¿î¿µµÇ°í ÀÖ´Â °¡¿îµ¥ ÀǷẸÇè ÅëÇÕÀÇ ¹è°æ°ú Çʿ伺°ú ÅëÇÕÀÇ ´çÀ§¼º¿¡ ´ëÇÑ ÀÔÀåÀ» ¼Ò°³Çϰí ÀÖ´Ù. ¶Ç ÅëÇÕÀǷẸÇè¾È³», ÅëÇÕÀÇ ´çÀ§¼º, ÅëÇÕ ¹Ý´ëÀǰ߿¡ ´ëÇÑ ´äº¯, ÀǺ¸ÅëÇÕ¿¡ ´ëÇÑ ÀÔÀå, ½É»çÆò°¡¿øµîÀÇ ÄÁÅÙÃ÷·Î ±¸¼ºµÅÀÖ´Ù. X AD ½ÉÆ÷Áö¾ö ´Ù½Ãº¸±â À̺¥Æ®Âü¿© ¡æ ¾È»ó¼ø ±âÀÚ(s2a@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀǺ¸°ø´Ü, ÀǷẸÇè ÅëÇÕ È¨ÆäÀÌÁö ±¸Ãà URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö